Digital Medicine, Genetic Information, and Health Technology Assessment: Perspectives from Japan, Korea, and Singapore
Few aspects of society are being transformed by technology more than health and medical care, with health systems challenged to finance and deliver affordable access to a burgeoning array of technologies enabling longer, healthier lives. Three speakers will address different and complementary aspects of how several Asian health systems create, evaluate, and regulate transformative technologies. Dr. Masuda’s research probes policies governing domestic and cross-border control and sharing of genetic information for medical innovation. Dr. Ahn will discuss health technology assessment (HTA) for pricing and reimbursement decisions in South Korea, where there is a young yet established HTA program, compared to Japan, where a 3-year HTA pilot program has just concluded, and China, where HTA efforts are underway but have not been formally implemented. Finally, Dr. Ho will discuss the emergence of digital medicine enabling N-of-1 regimen design for patients. Truly individualizing patient treatment requires addressing a series of challenges, from dynamic patient response to treatment regimens, to accounting for drug synergies in combination therapies which can be dose-dependent, time-dependent, and patient-specific, such as in oncology. Dr. Ho will summarize several clinical studies aiming to increase accessibility to personalized, precision medicine while reducing healthcare costs.
Via Zoom Webinar
Register: https://bit.ly/3GGqOhv
Sachiko Masuda
Sachiko Masuda joined the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2021-22 academic year from the University of Tokyo, Research Center for Advanced Science and Technology, where she serves as an associate professor.
Masuda is dedicated to the study of legal systems and regulations, infrastructure, and industrial structures necessary for advances in technology and a safer society, especially in the pharmaceutical and medical fields. During her time at Shorenstein APARC, Masuda conducted a comparative study between the US and Japan regarding “Human genetic information for medical innovation: Examining policy issues related to domestic and cross-border sharing and ensuring control” with Professor Karen Eggleston.
Masuda received a Ph.D. in Arts and Sciences (specializing in intellectual property law) in 2006 and a B.S. in Pharmaceutical Sciences in 1997 from the University of Tokyo. She is a registered patent attorney and pharmacist in Japan.
